Wanhai Xu

机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0003-3442-7988

发表论文 225 篇 · 总被引 5218 次 · h-index 41

代表论文

• Cascade-Activatable Nanoprodrug System Augments Sonochemotherapy of Bladder Cancer (2024 · ACS Nano · 被引 29)
• Intracellular aggregation of exogenous molecules for biomedical applications (2025 · Chemical Society Reviews · 被引 28)
• In vivo self-assembled bispecific fluorescence probe for early detection of bladder cancer and metastasis (2024 · 中国科学通报：英文版 · 被引 24)
• Synergistic Enhancement of Ferroptosis via Mitochondrial Accumulation and Photodynamic-Controlled Release of an Organogold(I) Cluster Prodrug (2025 · Journal of the American Chemical Society · 被引 21)
• In Situ Transformable Nanoparticle Effectively Suppresses Bladder Cancer by Damaging Mitochondria and Blocking Mitochondrial Autophagy Flux (2024 · Advanced Science · 被引 20)
• Associations of prognostic nutritional index with cardiovascular all-cause mortality among CVD patients with diabetes or prediabetes: evidence from the NHANES 2005–2018 (2025 · Frontiers in Immunology · 被引 18)